Skip to content

CONMED CNMD Deferred Taxes

Deferred Taxes at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
$7.01B+189%
Boston Scientific logo
Boston ScientificBSX
$219M+38.6%
OSI Systems logo
OSI SystemsOSIS
$1.44M
IAR
Integra LifeSciencesIART
$6.14M-89.3%
Zimmer Biomet Holdings logo
Zimmer Biomet HoldingsZBH
Medtronic logo
MedtronicMDT

Other financials

Income statement

See full
Revenue$317.0M-1.3%
Gross profit$183.4M+3.2%
Operating income$25.4M+59.3%
Net income$13.8M+129%
EPS (diluted)$0.45+137%

Balance sheet

See full
Cash & equivalents$35.0M-1.3%
Total debt$862.6M-3.6%
Total equity$1.0B+4.1%
Total assets$2.3B+0.8%

Cash flow

See full
Operating cash flow$13.5M-67.6%
CapEx$2.9M-23.5%
Free cash flow$10.6M-72.0%

Valuation

See full
Market cap$1.04B-35.6%
Enterprise value$1.87B-24.5%
P/E19×+5.4×
P/S0.8×-0.5×

Profitability

See full
Gross margin55.2%-1.0pp
Operating margin8.2%-5.6pp
Net margin4%-5.0pp
FCF margin9%-3.5pp

Returns & leverage

See full
Return on equity5.5%-7.5pp
Debt / equity0.8×-0.1×
Current ratio2.3×0.0×

Where this comes from

Reported directly by CONMED in its filing.

Tagged under the XBRL concept us-gaap:DeferredIncomeTaxLiabilitiesNet.

The official record: CONMED’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about CONMED's deferred taxes.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is CONMED's deferred taxes?
CONMED (CNMD) reported deferred taxes of $81.38M in Q1 2026.
How has CONMED's deferred taxes changed year-over-year?
CONMED's deferred taxes increased by 16.3% year-over-year, from $69.95M to $81.38M.
What is the long-term trend for CONMED's deferred taxes?
Over 5 years (2020 to 2025), CONMED's deferred taxes has grown at a 6.6% compound annual growth rate (CAGR), from $57.88M to $79.53M.
What does deferred taxes mean?
This represents the net amount of income taxes that will be payable in future periods due to temporary differences between the carrying amount of assets and liabilities for financial reporting and their tax bases. It reflects the long-term tax impact of accounting choices and depreciation schedules. Investors use this to understand future tax obligations and the impact of tax timing on cash flow.